课题基金 / 基金详情

The Peroxisome Biogenesis Disorders: From Bench to Bedside

The Peroxisome Biogenesis Disorders: From Bench to Bedside
过氧化物酶体生物发生障碍：从实验室到临床
批准号：
266456
负责人：
Braverman Nancy E
金额：
$50.87万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-09-01 至 2015-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=266456&lang=en
关键词：
Cell Biology Clinical Research Drug Screening Human Genetics Model Organisms Of Disease Peroxisome Disorders

项目摘要

项目成果

Braverman Nancy E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The PBD are inherited childhood conditions that are only moderately rare, but have been neglected in terms of clinical investigations and therapeutic interventions. They are caused by defects in any one of 14 peroxisome biogenesis genes and result in faul
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Toward clinical translation of retinal gene therapy for Zellweger Spectrum Disorder
Enabling commercialization of retinal gene therapy for Zellweger Spectrum Disorder
Developing retinal gene augmentation therapy for Zellweger Spectrum Disorder
Getting Ready for Vision Therapy in Peroxisome Biogenesis Disorders
海外基金